Objective To review and comment on current indica tions for radioiodine remnant ablation
(RRA) in patients with differentiated thyroid cancer. Methods The stratification of patients as
potential candidates for RRA, the benefits and risks of RRA, and the optimal preparation and
administered doses of iodine 131 for RRA are discussed. Results When RRA for patients
with low and inter mediate-risk differentiated thyroid cancer is being consid ered, the
benefits—including survival, influence on mor bidity and recurrence, and ease of monitoring …